Happy Health Core and the Nutrient Gaps It Closes

Chris Junge | Founder, Solprana | solprana.net

Disclosure: I founded Solprana, which makes Happy Health Core, and hold a financial interest in it. Every claim below is cited to a primary source or labeled as internal observation.

The Premise

Happy Health Core rests on three propositions. Adults in the United States commonly consume less than required of several nutrients central to energy metabolism and antioxidant defense. Regular cannabis users show lower blood levels of several specific vitamins and minerals. Core supplies those nutrients in bioactive forms at doses sufficient to close the gap. The first two propositions are supported by published data. Whether closing the gap improves function in a given person is a separate, testable question, and the final section sets out how to test it.

Inadequate Intake Is the Norm

NHANES data from 10,698 adults (2009–2012) show that in every adult age group more than 25 percent consume less than the Estimated Average Requirement (EAR) for magnesium and vitamins A, C, D, and E. The EAR is set at the intake that meets the needs of half of healthy individuals, so falling below it is a shortfall, not a missed optimum. From food alone, intake falls below the EAR in approximately 96 percent of adults for vitamin D, 87 percent for vitamin E, 55 percent for magnesium, and 46 percent for vitamin C. These are intake figures; biochemical deficiency is less prevalent, and the two should not be conflated. Evidence tier: high, for inadequate intake.

Regular Cannabis Users

In a Norwegian cohort of 666 patients with substance use disorders, weekly cannabis use was the only substance pattern associated with lower baseline 25-hydroxyvitamin D (−5.2 nmol/L), and a companion analysis associated it with lower serum folate.

These data are observational and come from a clinical population. Nutrient status is driven chiefly by socioeconomic factors and alcohol intake, and the cohort does not fully separate those from cannabis use. The supported conclusion, at a moderate evidence tier, is that regular cannabis use is associated with lower vitamin D and folate status.

Vascular data add a separate line of evidence. In the CANDIDE study (JAMA Cardiology, 2025), flow-mediated dilation averaged 10.4 percent in non-users, 6.0 percent in cannabis smokers, and 4.6 percent in THC-edible users, indicating impaired nitric oxide–dependent vasodilation. That finding identifies physiological demand on systems that depend on several nutrients in Core. No nutrient, and no product, has been shown to correct it; our Science Library article “Beyond the Diagnosis” reviews the full literature.

Magnesium carries the strongest mechanistic case in the formula, and its absence from the cannabis blood literature reflects a measurement problem, not a negative finding. Serum holds about 1 percent of body magnesium and is held within range by renal regulation even as intracellular stores decline, so the inexpensive standard test cannot detect the insufficiency in question. Red blood cell and tissue magnesium, the informative measures, cost more and have not been measured in cannabis users. The demand side is well characterized. ATP is biologically active chiefly as Mg–ATP; magnesium gates the NMDA receptor, stabilizes cardiac rhythm, and regulates vascular smooth muscle tone; and it is required for the enzymatic activation of vitamin D, one of the two nutrients measurably lower in regular users. Cannabinoid signaling through CB1 acts on neuronal excitability, mitochondrial activity, autonomic tone, and, as CANDIDE shows, vascular function, each a magnesium-dependent system. In a population where more than half of adults already consume less than the EAR, regular users draw on a reserve most people have not filled. This is a mechanistic inference rather than a measured outcome, and red blood cell magnesium testing can confirm or refute it directly.

Formulation

Core contains no THC or CBD. It is a three-capsule daily vitamin and mineral formula, with each component chosen for a documented gap and delivered in a form the body uses directly.

Magnesium, 200 mg, as Albion® bisglycinate chelate. Magnesium is a cofactor in more than 300 enzymatic reactions, and ATP is biologically active chiefly as a magnesium–ATP complex. The chelate is better absorbed and better tolerated than magnesium oxide. Its inclusion rests on the national intake gap and the demand model described above.

Vitamin D3, 50 mcg (2,000 IU), with vitamin K2 as MK-7, 120 mcg. Vitamin D has the widest intake gap in NHANES and is one of the nutrients most consistently lower in cannabis users. Vitamin D increases calcium absorption; vitamin K–dependent proteins direct that calcium toward bone and away from soft tissue.

Zinc, 25 mg, as picolinate, with copper, 2 mg, and selenium, 100 mcg, as L-selenomethionine. Zinc supports immune function and more than 300 enzymes, and intake falls short in a substantial share of older adults. Copper is included because sustained zinc intake without it impairs copper absorption. Selenium is required for glutathione peroxidase, a principal antioxidant enzyme.

Vitamin C, 500 mg, and vitamin E, 134 mg (200 IU). Both show large national intake gaps; vitamin C regenerates vitamin E after it quenches lipid radicals in cell membranes. The U.S. Preventive Services Task Force (2022) found no net benefit of vitamin E supplementation for preventing cardiovascular disease or cancer and recommends against it for that purpose. Vitamin E is included to correct documented shortfalls, not for disease prevention.

B-complex in active forms. Thiamin 20 mg, riboflavin-5′-phosphate 20 mg, niacin as niacinamide 30 mg, pantothenic acid 50 mg, pyridoxal-5′-phosphate 20 mg, folate as Quatrefolic® 5-MTHF 680 mcg DFE, methylcobalamin 500 mcg, and biotin 300 mcg. These are the coenzymes through which cells oxidize glucose, fatty acids, and amino acids to produce ATP. The active forms bypass conversion steps that vary between individuals. Folate and B12 also regulate homocysteine, an established cardiovascular risk marker.

Chromium, 200 mcg, and manganese, 2 mg, complete the mineral cofactors for glucose handling and antioxidant enzymes.

Controlled Evidence for Broad Formulas

Core itself has not been tested in a controlled trial. The nearest evidence comes from comparable formulas. In a double-blind, placebo-controlled trial of 82 healthy adults (Dodd et al., 2020), a multivitamin-mineral providing about three times the RDA of water-soluble vitamins increased energy expenditure during demanding cognitive tasks after a single dose and at 28 days, and reduced mental tiredness during exercise, with a larger effect at day 28, consistent with progressive repletion. Blinding held. This trial is the reference point for Core’s dosing. Core provides more than three times the RDA of thiamin, riboflavin, vitamin B6, vitamin B12, pantothenic acid, biotin, and vitamin C; niacin (about twice the RDA) and folate (about 1.7 times the RDA) sit below that level. The formula differed from Core, the participants were young non-smokers, several effects appeared in one sex only, and the authors cautioned against generalization.

For long-term disease outcomes, the 2022 Task Force review found the evidence insufficient to determine whether multivitamins prevent cardiovascular disease or cancer. Core is not positioned as disease prevention. Its purpose is narrower and measurable: correct nutrient shortfalls and support the processes that depend on them.

Internal Observations

Adam Jacques and I each completed a structured 30-day self-trial, logging blood pressure, heart rate, and daily 0–10 ratings across six domains. My evening systolic pressure declined from 123 to 114 mmHg, and diastolic pressure held in the low-to-mid 70s over the final ten days; I also recorded faster recovery after disrupted sleep and less persistent rumination, with low days still occurring. Comparing days 1–10 with days 16–30, Adam’s morning systolic pressure fell from 132.8 to 128.5 mmHg and diastolic from 85.9 to 82.9 mmHg, with lower reported anxiety and better sleep.

These are two unblinded, uncontrolled subjects who knew what they were taking. Adam’s period overlapped with a marked increase in hiking and physical labor, which alone could account for his change, and five days of his data are missing. The observations are hypothesis-generating and are reported because they define what we will measure next.

Testing the Outcome

Because the case for Core concerns measurable nutrient status, it can be tested in any individual. Before starting, obtain serum 25-hydroxyvitamin D, red blood cell magnesium, vitamin B12 with methylmalonic acid, serum folate, and plasma homocysteine. For one week, record blood pressure and resting heart rate at a fixed time daily and rate energy, sleep, and mood from 0 to 10.

Take Core for 60 to 90 days, the interval over which vitamin D and red blood cell magnesium equilibrate, then repeat the labs and the logging week. The repletion model predicts a specific pattern: laboratory values rise, and functional measures improve most in those who started lowest. No change in someone who started replete is an equally informative result. The same design, applied to a cohort of regular cannabis users, is the next phase of our research.

Clinical Cautions

People taking prescription anticoagulants should consult their prescriber first, because vitamin K alters the effect of some of these drugs. The same applies during pregnancy or breastfeeding, in kidney disease, which impairs mineral clearance, and for anyone already taking separate vitamin D, zinc, or multivitamin products.

Summary

Most adults fall short on nutrients the body cannot synthesize, and regular cannabis users show lower vitamin D and folate status alongside added demand on magnesium-dependent systems. Happy Health Core addresses those specific gaps with bioactive forms at meaningful doses. Whether that produces measurable change in a given person can be determined with standard laboratory tests over a single season, and that is the standard on which we ask to be judged.

References

1. Blumberg JB, Frei B, Fulgoni VL, Weaver CM, Zeisel SH. Contribution of dietary supplements to nutritional adequacy in various adult age groups. Nutrients. 2017;9(12):1325. doi:10.3390/nu9121325
2. Ikonte CJ, Mun JG, Reider CA, Grant RW, Mitmesser SH. Micronutrient inadequacy in short sleep: analysis of the NHANES 2005–2016. Nutrients. 2019;11(10):2335. PMC6835726
3. Vitamin D status and associations with substance use patterns among people with severe substance use disorders in Western Norway. Sci Rep. 2022. doi:10.1038/s41598-022-17804-w
4. Folate status as a nutritional indicator among people with substance use disorder: a prospective cohort study in Norway. Nutrients. 2022. PMC9099634
5. de Baaij JHF, Hoenderop JGJ, Bindels RJM. Magnesium in man: implications for health and disease. Physiol Rev. 2015;95(1):1–46.
6. Elin RJ. Assessment of magnesium status for diagnosis and therapy. Magnes Res. 2010;23(4):S194–S198.
7. Uwitonze AM, Razzaque MS. Role of magnesium in vitamin D activation and function. J Am Osteopath Assoc. 2018;118(3):181–189.
8. Mohammadi L, Navabzadeh M, Jiménez-Téllez N, et al. Association of endothelial dysfunction with chronic marijuana smoking and THC-edible use. JAMA Cardiol. 2025. doi:10.1001/jamacardio.2025.1399
9. Dodd FL, Kennedy DO, Stevenson EJ, et al. Acute and chronic effects of multivitamin/mineral supplementation on objective and subjective energy measures. Nutr Metab (Lond). 2020;17:16. doi:10.1186/s12986-020-00435-1
10. US Preventive Services Task Force; Mangione CM, Barry MJ, et al. Vitamin, mineral, and multivitamin supplementation to prevent cardiovascular disease and cancer: US Preventive Services Task Force recommendation statement. JAMA. 2022;327(23):2326–2333. doi:10.1001/jama.2022.8970

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. This article is educational and is not a substitute for individual medical advice.